Skip to main content
. 2022 Nov 8;50(3):849–858. doi: 10.1007/s00259-022-06016-z

Fig. 3.

Fig. 3

a Biodistribution of [211At]PSMA5 and [211At]PSMA6 in normal ICR mice. b Biodistribution of [211At]PSMA1, [211At]PSMA5, and [211At]PSMA6 in LNCaP xenograft model (NOD/SCID mice). Data are expressed as mean ± standard deviation. Total excretion (%ID) of [211At]PSMA1 and [211At]PSMA5 were 0.49 ± 0.37% and 8.26 ± 5.00 % at 3h and 14.7 ± 10.0% and 15.33 ± 6.3% at 24h in the urine, and 14.0 ± 4.8% and 35.2 ± 9.2% at 24h in the feces, respectively. Total excretion (%ID) of [211At]PSMA6 at 24h were 6.20 ± 1.51% in the urine, and 9.78 ± 0.79% in the feces, respectively